Eric M. Green is the President, Chief Executive Officer, and Chair of the Board of West Pharmaceutical Services, Inc. (NYSE: WST). Green has led West Pharmaceutical since April 2015 and became Chair in May 2022. Under his decade-long leadership, the specialty pharmaceutical supplier surpassed $3 billion in annual net sales for the first time in 2025, posted 8% adjusted EPS growth, and delivered 70% free cash flow growth. Before joining West, Green spent over 20 years at Sigma-Aldrich Corporation, rising from sales representative to EVP and President of Research Markets. West manufactures the injectable drug containment and delivery components — vials, stoppers, syringe systems, and self-injection platforms — that pharmaceutical and biotech companies depend on to safely deliver medications worldwide.
Read on to discover West Pharmaceutical CEO Eric Green’s email address, net worth in 2026, salary and compensation, career history, education, and more.
Quick Facts
| Eric M. Green — At a Glance | |
|---|---|
| Full Name | Eric M. Green |
| Position | President, CEO & Chair of the Board |
| Company | West Pharmaceutical Services, Inc. (NYSE: WST) |
| Age | ~55 years (as of 2026) |
| Education | B.S. Chemistry, Bethel University; MBA, Olin Business School, Washington University in St. Louis |
| Net Worth (Est.) | $40–50 Million |
| Total Compensation (2024) | ~$8.4 Million |
| CEO Since | April 2015 |
| Chair Since | May 2022 |
| Previous Role | EVP & President, Research Markets, Sigma-Aldrich |
| Headquarters | Exton, Pennsylvania |
| Employees | 10,000+ |
Career Highlights
- Decade of Leadership: Green has served as CEO of West Pharmaceutical Services since April 2015, making him one of the longest-tenured CEOs in the pharma services sector.
- $3 Billion Milestone: Under his leadership, West crossed the $3 billion net sales mark for the first time in FY2025, with reported revenue of $3.074 billion.
- COVID-19 Response: West’s containment components were critical to the global COVID-19 vaccine rollout, enabling billions of doses to be safely stored and delivered worldwide.
- Margin Expansion: Delivered consistent operating margin improvement and 70% free cash flow growth in FY2025.
- Board Chair Appointment: Named Chair of the Board in May 2022, consolidating leadership of the company.
- Sigma-Aldrich Career: Rose from sales representative to EVP and President of Research Markets over a 20+ year career at Sigma-Aldrich Corporation before joining West.
Eric Green Net Worth & Salary
As of 2026, Eric Green’s estimated net worth is approximately $40–50 million, primarily derived from his West Pharmaceutical Services stock holdings. According to SEC filings, Green directly holds approximately 175,161 shares of WST stock, worth roughly $44 million at current share prices (~$251 per share). He also holds additional shares through a deferred compensation plan.
Green’s total compensation for fiscal year 2024 was approximately $8.4 million. His base salary was $1.177 million, with an AIP (annual incentive) target of 125% of base salary and a long-term incentive target of $6.8 million. However, his annual bonus payout was only 20% of target ($294,690) due to below-target financial results in FY2024.
CEO Compensation Breakdown
| Component | FY2024 | Notes |
|---|---|---|
| Base Salary | $1,177,290 | Annual base pay |
| Annual Incentive (AIP) | $294,690 | 20% of 125% target; below-target year |
| Long-Term Incentives (LTI) | ~$6,800,000 | RSUs and performance shares |
| Other Compensation | ~$131,000 | Pension, perks, deferred comp |
| Total Compensation | ~$8,400,000 | FY2024 Total |
Key Insight: The industry median for CEO compensation at life sciences companies with market caps above $8 billion is approximately $12 million, placing Green’s FY2024 total below the peer median. His AIP payout reflected the company’s organic sales decline of 1.5% in FY2024 before the strong recovery in FY2025.
West Pharmaceutical Services Financial Summary
West Pharmaceutical Services delivered a strong recovery in FY2025 after a challenging FY2024. The company surpassed $3 billion in net sales for the first time, posting 6.3% reported revenue growth and 4.3% organic growth. Adjusted EPS grew 8.0% to $7.29, and free cash flow surged 69.6% to $468.9 million.
| Metric | FY2025 | FY2024 | YoY Change |
|---|---|---|---|
| Net Sales | $3.074B | $2.893B | +6.3% |
| Organic Net Sales Growth | 4.3% | -1.5% | +5.8pp |
| Adjusted Diluted EPS | $7.29 | $6.75 | +8.0% |
| Operating Cash Flow | $754.8M | $653.3M | +15.5% |
| Free Cash Flow | $468.9M | $276.5M | +69.6% |
| Market Capitalization | ~$18.1B | — | — |
| Stock Price (Mar 2026) | ~$251 | — | — |
2026 Guidance: West expects FY2026 net sales of $3.215–$3.275 billion (4.6%–6.5% growth) and adjusted diluted EPS of $7.85–$8.20 (7.7%–12.5% growth), signaling continued momentum.
West Pharmaceutical Competitors
West Pharmaceutical Services operates in the specialty pharmaceutical packaging and drug delivery systems industry. Its key competitors include:
- Terumo Corporation — Japanese medical device and pharmaceutical company
- Gerresheimer AG — German specialty glass and plastic products for pharma
- Schott AG — German glass manufacturer with pharma packaging division
- Nipro Corporation — Japanese manufacturer of medical devices and pharma packaging
- Becton Dickinson (BD) — Global medical technology company, syringes and injection systems
- Baxter International — Medical products including drug delivery systems
- Aptar Pharma — Drug delivery and packaging solutions
Eric Green Email & Contact Information
Below are the official contact details for West Pharmaceutical Services CEO Eric Green:
| Contact Information | |
|---|---|
| Email (Corporate) | [email protected] |
| Investor Relations | [email protected] |
| Corporate HQ | 530 Herman O. West Drive, Exton, PA 19341 |
| Phone | (610) 594-2900 |
| Website | westpharma.com |
| Eric Green – President, CEO and Chair at West Pharmaceutical Services | |
Career & Education – Company, University & College
Eric Green’s career spans over three decades in the life sciences and pharmaceutical services industries. Below is his complete career timeline:
Eric Green Career Timeline
| Period | Role | Organization |
|---|---|---|
| 1993 | B.S. Chemistry | Bethel University, Minnesota |
| 1993–2015 | Sales Rep → EVP & President, Research Markets | Sigma-Aldrich Corporation |
| — | MBA | Olin Business School, Washington University in St. Louis |
| Apr 2015 | President & CEO | West Pharmaceutical Services |
| May 2022 | Also named Chair of the Board | West Pharmaceutical Services |
Education
| University | Degree / Program |
|---|---|
| Bethel University, St. Paul, Minnesota | Bachelor of Science in Chemistry (Class of 1993) |
| Olin Business School, Washington University in St. Louis | Master of Business Administration (MBA) |
Green began his career as a sales representative at Sigma-Aldrich Corporation immediately after graduating from Bethel University in 1993. Over the next 22 years, he rose through the ranks to become Executive Vice President and President of the Research Markets business unit. He earned his MBA from the prestigious Olin Business School at Washington University in St. Louis during his tenure at Sigma-Aldrich. In April 2015, he was recruited to lead West Pharmaceutical Services as President and CEO.
Eric Green Wiki – Age, Family & More
West Pharmaceutical CEO Eric M. Green is approximately 55 years old as of 2026. He is based in the greater Philadelphia area near West’s headquarters in Exton, Pennsylvania. Green keeps his personal and family life private, and specific details about his spouse and children are not publicly available.
Green is a chemistry major turned business leader who brings a scientific background to leading a company whose products are deeply technical. He has spoken about how his chemistry training informs his approach to innovation and quality at West Pharmaceutical Services.
Notable Recognition
- Titan 100 (2023) — Named to the Philadelphia Titan 100, recognizing the top 100 CEOs and C-level executives in the region
- Bethel University Distinguished Alumni — Featured as a notable alumnus of his alma mater
- COVID-19 Response Leadership — Led West’s critical role in enabling global vaccine delivery during the pandemic
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. is a leading global manufacturer of injectable drug containment and delivery systems, headquartered in Exton, Pennsylvania. Founded in 1923, the company has over 100 years of history in the pharmaceutical supply chain.
West designs, manufactures, and sells products used in the packaging, containment, and delivery of injectable medicines. Its products include:
- Stoppers and seals — rubber components that seal injectable drug vials
- Syringe and cartridge components — plungers, tip caps, and needle shields
- Self-injection systems — SmartDose and SelfDose platforms for patient self-administration
- NovaPure and FluroTec — advanced high-value product lines with proprietary coatings
- Analytical laboratory services — testing and characterization for drug containment
West trades on the NYSE under the ticker WST. The company employs over 10,000 people across approximately 50 manufacturing and operations sites worldwide. Its components are used to contain and deliver billions of doses of injectable drugs and vaccines globally each year.
Frequently Asked Questions (FAQ)
Who is the CEO of West Pharmaceutical Services?
Eric M. Green has served as President, CEO, and Chair of the Board of West Pharmaceutical Services since 2015 (Chair since 2022). Under his leadership, the company surpassed $3 billion in annual net sales for the first time in FY2025.
What is Eric Green’s net worth in 2026?
Eric Green’s estimated net worth in 2026 is approximately $40–50 million, primarily based on his SEC-disclosed holdings of about 175,161 shares of West Pharmaceutical Services stock, valued at roughly $44 million at current prices.
What is West Pharmaceutical CEO’s salary?
Eric Green’s total compensation for fiscal year 2024 was approximately $8.4 million, including a $1.177 million base salary, $294,690 annual incentive, approximately $6.8 million in long-term equity incentives, and $131,000 in other compensation.
What is the West Pharmaceutical CEO email address?
Eric Green can be contacted at [email protected]. For investor relations inquiries, use [email protected]. The corporate phone number is (610) 594-2900.
What does West Pharmaceutical Services make?
West manufactures injectable drug containment and delivery systems — including rubber stoppers, vial seals, syringe components, and self-injection platforms. Its products are essential for safely packaging and delivering billions of doses of injectable drugs and vaccines worldwide.
Is West Pharmaceutical Services profitable?
Yes, West Pharmaceutical Services is highly profitable. In FY2025, the company reported $3.074 billion in net sales (up 6.3%), adjusted diluted EPS of $7.29 (up 8.0%), and free cash flow of $468.9 million (up 69.6%). Its market capitalization is approximately $18 billion as of March 2026.
Article last updated: March 5, 2026
Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings, official company press releases, and reputable news outlets. This content is provided for informational purposes only and does not constitute financial or investment advice. Net worth figures are estimates and may vary by source.